BioNexus Gene Lab Corp [NASDAQ: BGLC] traded at a high on 2025-07-01, posting a 262.87 gain after which it closed the day’ session at $622400.0.
The results of the trading session contributed to over 50360527 shares changing hands. Over the past one week, the price volatility of BioNexus Gene Lab Corp stands at 23.77% while the volatility over the past one month is 13.26%.
The market cap for BGLC stock reached $20.03 million, with 1.80 million shares outstanding and 1.17 million shares in the current float. Compared to the average trading volume of 622.40K shares, BGLC reached a trading volume of 50360527 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about BioNexus Gene Lab Corp [BGLC]?
The Price to Book ratio for the last quarter was 2.58, with the Price to Cash per share for the same quarter was set at 2.00.
How has BGLC stock performed recently?
BioNexus Gene Lab Corp [BGLC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 317.23. With this latest performance, BGLC shares gained by 159.67% in over the last four-week period, additionally plugging by 362.24% over the last 6 months – not to mention a rise of 298.28% in the past year of trading.
BioNexus Gene Lab Corp [BGLC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and BioNexus Gene Lab Corp [BGLC] shares currently have an operating margin of -24.74% and a Gross Margin at 12.78%. BioNexus Gene Lab Corp’s Net Margin is presently recorded at -22.86%.
Return on Equity for this stock declined to -20.52%, with Return on Assets sitting at -20.52%.
Insider trade positions for BioNexus Gene Lab Corp [BGLC]
There are presently around $0.88%, or 1.80%% of BGLC stock, in the hands of institutional investors.
